Skip Navigation



Annals of Oncology Advance Access published online on April 13, 2007

Annals of Oncology, doi:10.1093/annonc/mdm105
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
18/7/1172    most recent
mdm105v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Devi, B.
Right arrow Articles by Corbex, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devi, B.
Right arrow Articles by Corbex, M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia

BCR Devi1,*, TS Tang1 and M Corbex2

1 Department of Radiotherapy and Oncology, Sarawak General Hospital, Sarawak, Malaysia
2 Eastern Mediterranean Regional Office of World Health Organization, Cairo, Egypt

* Correspondence to: Dr B. C. R. Devi, Department of Radiotherapy and Oncology, Sarawak General Hospital, 93586 Kuching, Sarawak, Malaysia. Tel: +60-82-276666; Fax: +60-82-242087; E-mail: beenadevicr{at}gmail.com

Background: The registry of the Oncology Departmental in Sarawak General Hospital showed that 79% of nasopharyngeal, 77% of breast and 70% of cervix cancer patients were diagnosed at an advanced stage (stages III and IV) for year 1993. Hence, a low cost Early Cancer Surveillance Program was started in 1994, with the intent of downstaging these three most common cancers in Sarawak.

Materials and methods: The program consisted of (i) training health staff in hospital and rural clinics to improve their skills in early cancer detection, (ii) raising public awareness through pamphlets, posters and sensitization by health staff.

Results: Data analysis revealed that the program achieved downstaging in two of the cancers. Breast cancer in stage III and IV was reduced from 60% (1994) to 35% (1998) (P < 0.0001) and cervical cancer in stage III and IV from 60% (1994) to 26% (1998) (P < 0.0001). No reduction was observed for nasopharyngeal cancer at 88% (1994) to 91% (1998).

Conclusions: The overall cost of this program was <US$34 000. It is cost-effective and easy to implement and would be a valuable alternative in countries where majority of the tumors are found in late stage (III and IV) where screening programs meet important difficulties. Our data analyses revealed important shortcomings in the PAP smear screening program where inadequate groups of women were screened. It resulted in a pick up rate of only 5% of the cases. This finding confirmed the need for the simple and complementary downstaging approach.

breast cancer, cervix cancer, clinical downstaging, NPC

Received for publication December 1, 2006. Accepted for publication February 19, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann OncolHome page
B. C. R. Devi, T. S. Tang, and M. Corbex
Setting up home-based palliative care in countries with limited resources: a model from Sarawak, Malaysia
Ann. Onc., December 1, 2008; 19(12): 2061 - 2066.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.